HU9600725D0 - Transdermal device containing (e)-2-(p-fluorophenethyl)-3-fluoroallylamine for the treatment of alzheimer's disease - Google Patents

Transdermal device containing (e)-2-(p-fluorophenethyl)-3-fluoroallylamine for the treatment of alzheimer's disease

Info

Publication number
HU9600725D0
HU9600725D0 HU9600725A HU9600725A HU9600725D0 HU 9600725 D0 HU9600725 D0 HU 9600725D0 HU 9600725 A HU9600725 A HU 9600725A HU 9600725 A HU9600725 A HU 9600725A HU 9600725 D0 HU9600725 D0 HU 9600725D0
Authority
HU
Hungary
Prior art keywords
fluoroallylamine
fluorophenethyl
alzheimer
disease
treatment
Prior art date
Application number
HU9600725A
Other languages
Hungarian (hu)
Other versions
HUT75877A (en
Inventor
Ian A Mcdonald
Michael G Palfreyman
Daniel Yu
Original Assignee
Merrell Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Pharma Inc filed Critical Merrell Pharma Inc
Publication of HU9600725D0 publication Critical patent/HU9600725D0/en
Publication of HUT75877A publication Critical patent/HUT75877A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
HU9600725A 1993-09-24 1994-08-23 Transdermal device containing (e)-2-(p-fluorophenethyl)-3-fluoroallylamine for the treatment of alzheimer's disease HUT75877A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US12719093A 1993-09-24 1993-09-24

Publications (2)

Publication Number Publication Date
HU9600725D0 true HU9600725D0 (en) 1996-05-28
HUT75877A HUT75877A (en) 1997-05-28

Family

ID=22428772

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9600725A HUT75877A (en) 1993-09-24 1994-08-23 Transdermal device containing (e)-2-(p-fluorophenethyl)-3-fluoroallylamine for the treatment of alzheimer's disease

Country Status (10)

Country Link
EP (1) EP0720475A1 (en)
JP (1) JPH09505276A (en)
CN (1) CN1131390A (en)
AU (1) AU684545B2 (en)
CA (1) CA2172605A1 (en)
HU (1) HUT75877A (en)
IL (1) IL111017A0 (en)
NO (1) NO961180D0 (en)
WO (1) WO1995008325A1 (en)
ZA (1) ZA947262B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100479405B1 (en) * 2002-05-24 2005-03-30 주식회사 싸이제닉 Cinnamic acid dimers, their preparation and the use thereof for treating neurodegenerative disease
WO2010033045A1 (en) * 2008-09-16 2010-03-25 Igor Anatolievich Pomytkin Compositions and methods for prevention or treatment of beta amyloid deposition

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4861800A (en) * 1987-08-18 1989-08-29 Buyske Donald A Method for administering the drug deprenyl so as to minimize the danger of side effects
EP0642338B1 (en) * 1992-05-27 1997-01-22 Merrell Pharmaceuticals Inc. USE OF (E)-2-(p-FLUOROPHENETHYL)-3-FLUOROALLYLAMINE IN THE TREATEMENT OF ALZHEIMER'S DISEASE

Also Published As

Publication number Publication date
NO961180L (en) 1996-03-22
AU684545B2 (en) 1997-12-18
JPH09505276A (en) 1997-05-27
ZA947262B (en) 1995-05-23
CA2172605A1 (en) 1995-03-30
EP0720475A1 (en) 1996-07-10
AU7636494A (en) 1995-04-10
IL111017A0 (en) 1994-11-28
CN1131390A (en) 1996-09-18
HUT75877A (en) 1997-05-28
NO961180D0 (en) 1996-03-22
WO1995008325A1 (en) 1995-03-30

Similar Documents

Publication Publication Date Title
EP0735870A4 (en) Use of pla 2? inhibitors as treatment for alzheimer's disease
IL106877A0 (en) Compounds useful as hypoglycemic agents and for treating alzheimer's disease
EP1043991A4 (en) Treatment for alzheimer's disease
IL112050A0 (en) Methods of inhibiting alzheimer's disease
EP0541686A4 (en) Tachykinin agonists for treatment of alzheimer's disease
EP1007048A4 (en) Identification of agents for use in the treatment of alzheimer's disease
EP0331620A3 (en) Agent for the treatment of parkinson's disease
HUP0003852A3 (en) Use of highly selective butyrylcholinesterase inhibitors for the treatment and diagnosis of alzheimer's disease and dementias
IL86423A0 (en) Pharmaceutical compositions for the treatment of alzheimer's disease
IL127146A0 (en) Transdermal propentofylline compositions for the treatment of alzheimer's disease
IL117695A0 (en) Pharmaceutical agents for the treatment of alzheimer's disease
GB9323808D0 (en) Composition containing zinc for the treatment of skin disorders
ITMI931181A1 (en) PROCEDURE FOR ADDITIONAL SALCICCE TREATMENT
HU9600725D0 (en) Transdermal device containing (e)-2-(p-fluorophenethyl)-3-fluoroallylamine for the treatment of alzheimer's disease
ZA924128B (en) New combination preparations for treatment of Parkinson's disease.
EP0667139A4 (en) Device for enhancing human work fitness: "kuznetsov applicator".
GB2275191B (en) Use of antifungal compounds in the treatment of skin disorders
EG20501A (en) Process for the agrochemical treatment of grasslands
AU1455395A (en) Use of m3 muscarinic antagonists for the treatment of motion sickness
AU6955294A (en) Agents for the prevention and treatment of parkinson's disease
GB9709416D0 (en) Methods for treatment of alzheimer's disease using azaspiranes
GB8925512D0 (en) Therapy for alzheimer's disease
SI1007040T1 (en) Use of phanquinone for the treatment of alzheimer's disease
GB8825491D0 (en) Therapy for alzheimer's disease
AU2002301084A1 (en) Identification of agents for use in the treatment of alzheimer's disease

Legal Events

Date Code Title Description
DFC4 Cancellation of temporary protection due to refusal